Phase 1 Nasopharyngeal Carcinoma Clinical Trials
11 recruitingPhase 1
What is a Phase 1 trial?
Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.
Showing 1–11 of 11 trials
Recruiting
Phase 1
[212Pb]VMT-Alpha-NET in Metastatic or Inoperable Somatostatin-Receptor Positive Gastrointestinal Neuroendocrine Tumors, Pheochromocytoma/Paragangliomas, Small Cell Lung, Renal Cell, and Head and Neck Cancers
Nasopharyngeal CarcinomaKidney CancersEsthesioneuroblastoma+7 more
National Cancer Institute (NCI)120 enrolled1 locationNCT06479811
Recruiting
Phase 1
Phase I Study of Becotatug Vedotin for Safety and Efficacy in EGFR-Positive Pediatric Relapsed/Refractory or Metastatic Solid Tumors
NeuroblastomaNasopharyngeal CarcinomaRhabdomyosarcoma+7 more
Sun Yat-sen University51 enrolled1 locationNCT07584499
Recruiting
Phase 1Phase 2
EGFR Antibody Combined With PD-1 Inhibitor and Chemotherapy in R/M Nasopharyngeal Carcinoma
Nasopharyngeal Cancinoma (NPC)Metastatic Nasopharyngeal CarcinomaRecurrent Nasopharynx Carcinoma
Sun Yat-sen University148 enrolled1 locationNCT06802835
Recruiting
Phase 1
TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous Cell Cancer
Metastatic Head and Neck Squamous Cell CarcinomaStage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8Recurrent Head and Neck Squamous Cell Carcinoma+20 more
Emory University40 enrolled2 locationsNCT06868433
Recruiting
Phase 1Phase 2
A Study of YL201 in Combination With Toripalimab and With or Without Cisplatin in Nasopharyngeal Carcinoma.
Recurrent or Metastatic Nasopharyngeal Carcinoma
MediLink Therapeutics (Suzhou) Co., Ltd.202 enrolled20 locationsNCT07258979
Recruiting
Phase 1Phase 2
SSTR2 Imaging With [68Ga]Ga-DOTA-TOC PET/CT in NPC
Nasopharyngeal Carcinoma (NPC)
University Medical Center Groningen10 enrolled1 locationNCT06982300
Recruiting
Phase 1
Metastatic Nasopharyngeal Carcinoma
Metastatic Nasopharyngeal Carcinoma
Chen Xiaozhong47 enrolled1 locationNCT06886347
Recruiting
Phase 1
Concurrent Nab-paclitaxel with Intensity-modulated Radiation Therapy in Patients with Stage III-IVa Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma (NPC)
Sun Yat-sen University24 enrolled1 locationNCT06611150
Recruiting
Phase 1Phase 2
A Study of ILB2109 and Toripalimab in Patients With Advanced Solid Malignancies
Triple-Negative Breast CancerOvarian CancerCervical Cancer+7 more
Innolake Biopharm200 enrolled1 locationNCT05955105
Completed
Phase 1
Killer T cell Therapy for Nasopharyngeal Carcinoma
Epstein-Barr virus associated Nasopharyngeal Carcinoma
The University of Hong Kong50 enrolled1 locationACTRN12609000675224
Completed
Phase 1
Phase I Trial of Adoptive Immunotherapy for Stage III and IV Nasopharyngeal Carcinoma
Nasopharyngeal Carcinoma
Queensland Institute of Medical Research10 enrolled1 locationACTRN12607000191493